China Universal Asset Management Company’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,513
Closed -$244K 449
2024
Q1
$244K Buy
15,513
+6,241
+67% +$96.1K 0.03% 268
2023
Q4
$150K Buy
9,272
+7,246
+358% +$92.4K 0.03% 237
2023
Q3
$25.8K Buy
2,026
+997
+97% +$13.8K 0.01% 285
2023
Q2
$14.5K Hold
1,029
﹤0.01% 294
2023
Q1
$15.9K Buy
1,029
+342
+50% +$5.71K 0.01% 245
2022
Q4
$11.3K Buy
687
+62
+10% +$1.01K ﹤0.01% 217
2022
Q3
$12K Buy
+625
New +$9.81K 0.01% 190

Other funds holding DCPH

China Universal Asset Management Company's DCPH Position: Q2 2024 in Review

China Universal Asset Management Company sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 15,513 shares — an estimated $244K sold.

China Universal Asset Management Company first reported a position in DCPH in Q3 2022 and held it in 7 quarters. The position peaked at $244K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • China Universal Asset Management Company reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • China Universal Asset Management Company sold 15,513 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $244K.
  • China Universal Asset Management Company first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • China Universal Asset Management Company's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $244K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on China Universal Asset Management Company's 13F filing for Q2 2024, filed 19 Jul 2024.